spironolactone has been researched along with dihydroethidium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruder-Nascimento, T; Cau, SB; Lopes, RA; Manzato, CP; Mestriner, FL; Montezano, AC; Neves, KB; Nguyen Dinh Cat, A; Silva, MA; Tostes, RC; Touyz, RM | 1 |
1 other study(ies) available for spironolactone and dihydroethidium
Article | Year |
---|---|
Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus.
Topics: Aldosterone; Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Ethidium; Glucocorticoids; Insulin; Male; Mice; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Potassium; Reactive Oxygen Species; Receptors, Mineralocorticoid; Spironolactone | 2015 |